Julia Lopez MP: written questions
135 published records · newest first.
Written questions
Lord MandelsonForeign, Commonwealth and Development OfficeTabled 20 Feb 2026AnsweredUIN 114131More
Question: To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, if she will make an assessment of potential conflict of interest associated with the former US Ambassador and companies referenced in the investments announced during US stat
Answer: I refer the Hon. Member to the Government's response to the Urgent Question tabled on 12 February, the Written Ministerial Statement in the name of the Chief Secretary to the Prime Minister that same day, and Oral Statement on the 23 February which set ou...
Answered 2 Mar 2026
Original Parliament recordTrade Agreements: USADepartment for Science, Innovation and TechnologyTabled 20 Feb 2026AnsweredUIN 114130More
Question: To ask the Secretary of State for Science, Innovation and Technology, if she will provide an update on the establishment and membership of a ministerial-level working group as set out in the MOU for the UK-US Tech Prosperity Deal.
Answer: The United States is our close ally and tech partner, and we are committed to ensuring that bond delivers real benefits for hardworking people on both sides of the Atlantic.As the Prime Minister has stated, we are in daily contact with all the key figures...
Answered 26 Feb 2026
Original Parliament recordTrade Agreements: USADepartment for Science, Innovation and TechnologyTabled 20 Feb 2026AnsweredUIN 114126More
Question: To ask the Secretary of State for Science, Innovation and Technology, if she will provide an update on the latest formal negotiations with the US on the UK-US Tech Prosperity Deal; and whether a date for further formal negotiation meetings has been set.
Answer: The United States is our close ally and tech partner, and we are committed to ensuring that bond delivers real benefits for hardworking people on both sides of the Atlantic.As the Prime Minister has stated, we are in daily contact with all the key figures...
Answered 26 Feb 2026
Original Parliament recordTrade Agreements: USADepartment for Science, Innovation and TechnologyTabled 20 Feb 2026AnsweredUIN 114124More
Question: To ask the Secretary of State for Science, Innovation and Technology, what recent discussions she has had with her US counterparts on the resumption of negotiations on the UK-US Tech Prosperity Deal.
Answer: The United States is our close ally and tech partner, and we are committed to ensuring that bond delivers real benefits for hardworking people on both sides of the Atlantic.As the Prime Minister has stated, we are in daily contact with all the key figures...
Answered 26 Feb 2026
Original Parliament recordTrade Agreements: USADepartment for Science, Innovation and TechnologyTabled 20 Feb 2026AnsweredUIN 114123More
Question: To ask the Secretary of State for Science, Innovation and Technology, what recent discussions she has had with Cabinet colleagues on the resumption of negotiations on the UK-US Tech Prosperity Deal.
Answer: The United States is our close ally and tech partner, and we are committed to ensuring that bond delivers real benefits for hardworking people on both sides of the Atlantic.As the Prime Minister has stated, we are in daily contact with all the key figures...
Answered 26 Feb 2026
Original Parliament recordPupils: AttendanceDepartment for EducationTabled 10 Feb 2026AnsweredUIN 112454More
Question: To ask the Secretary of State for Education, whether the national approach to behaviour and attendance will include specific guidance on reasonable adjustments for pupils with speech and language challenges.
Answer: Some pupils, including pupils who have speech and language needs, may face additional challenges that can impact their behaviour and attendance.Specialist support, such as from speech and language therapists, can play an important role in breaking down co...
Answered 23 Feb 2026
Original Parliament recordTeachers: TrainingDepartment for EducationTabled 10 Feb 2026AnsweredUIN 112453More
Question: To ask the Secretary of State for Education, how much and what proportion of the funding for the SEND teacher training programme announced on 16 January 2026 will be allocated to training on speech, language and communication needs.
Answer: The special educational needs and disabilities (SEND) teacher training offer comprises an investment of over £200 million over the course of this Parliament. This significant investment forms a central pillar of the government’s SEND reform plans, helping...
Answered 18 Feb 2026
Original Parliament recordDrugs: VATTreasuryTabled 4 Feb 2026AnsweredUIN 110861More
Question: To ask the Chancellor of the Exchequer, whether her Department has directed HMRC to review the application of VAT upon medicines supplied free-of-charge via EAMS and other compassionate access schemes.
Answer: VAT is the UK’s second largest tax, forecast to raise £180 billion in 2025/26. Taxation is a vital source of revenue which helps to fund public services. The Early Access to Medicines Scheme (EAMS) allows patients access to free medicines for life threate...
Answered 9 Feb 2026
Original Parliament recordLife Sciences: TaxationDepartment for Science, Innovation and TechnologyTabled 4 Feb 2026AnsweredUIN 110860More
Question: To ask the Secretary of State for Science, Innovation and Technology, what discussions she has had with Cabinet colleagues on the impact of (a) VAT and (b) other taxation on the viability of the life sciences sector.
Answer: The Secretary of State has regular engagement with relevant colleagues on the UK business environment for life sciences sector, to drive the growth of the sector and support the delivery of the Life Sciences Sector Plan.
Answered 10 Feb 2026
Original Parliament recordDrugs: VATDepartment for Science, Innovation and TechnologyTabled 4 Feb 2026AnsweredUIN 110859More
Question: To ask the Secretary of State for Science, Innovation and Technology, what discussions she has had with the life sciences sector on the application of VAT on medicines supplied free-of-charge via EAMS and other compassionate access schemes.
Answer: The Secretary of State for Science, Innovation and Technology regularly engages with representatives of the life sciences sector. The issue of the application of VAT on medicines supplied free-of-charge via Early Access to Medicines Scheme (EAMS) and othe...
Answered 16 Feb 2026
Original Parliament recordLife SciencesDepartment of Health and Social CareTabled 4 Feb 2026AnsweredUIN 110858More
Question: To ask the Secretary of State for Health and Social Care, with reference to the correspondence from the Minister for Science, Innovation, Research and Nuclear to the Chair of the Science, Innovation and Technology Committee, dated 30 January 2026, if he w
Answer: There are no current plans to publish the joint analysis undertaken by the Department, NHS England, and the National Institute for Health and Care Excellence (NICE) on the cost of the United Kingdom and United States’ pharmaceutical trade deal.Tens of tho...
Answered 9 Feb 2026
Original Parliament recordGovernment Departments: ProcurementCabinet OfficeTabled 2 Feb 2026AnsweredUIN 110052More
Question: To ask the Minister for the Cabinet Office, what progress his Department has made on achieving the Government’s objectives for supporting Small and Medium-sized Enterprises participation in public procurement.
Answer: The Government is determined to ensure the £400 billion of public money spent on public procurement annually delivers economic growth and supports British businesses, especially SMEs. The Cabinet Office does not hold a central record of the proportion of ...
Answered 12 Feb 2026
Original Parliament recordGovernment Departments: ProcurementCabinet OfficeTabled 2 Feb 2026AnsweredUIN 110051More
Question: To ask the Minister for the Cabinet Office, what proportion of procurement contracts awarded by each Government Department were to Small and Medium-sized Enterprises in each of the last five financial years.
Answer: The Government is determined to ensure the £400 billion of public money spent on public procurement annually delivers economic growth and supports British businesses, especially SMEs. The Cabinet Office does not hold a central record of the proportion of ...
Answered 12 Feb 2026
Original Parliament recordGovernment Departments: ProcurementCabinet OfficeTabled 2 Feb 2026AnsweredUIN 110050More
Question: To ask the Minister for the Cabinet Office, what steps the Government Commercial Agency is taking to help improve access to Government procurement processes for (a) Small and Medium-sized Enterprises and (b) other suppliers with expertise in artificial in
Answer: The Government is determined to ensure the £400 billion of public money spent on public procurement annually delivers economic growth and supports British businesses, especially SMEs. The Cabinet Office does not hold a central record of the proportion of ...
Answered 12 Feb 2026
Original Parliament recordPublic Sector: Artificial IntelligenceCabinet OfficeTabled 2 Feb 2026AnsweredUIN 110049More
Question: To ask the Minister for the Cabinet Office, what steps her Department is taking to facilitate public sector access to Artificial Intelligence expertise through procurement; and how the Government Commercial Agency will (a) identify, (b) accredit and (c) e
Answer: The Crown Commercial Service (CCS) facilitates public sector access to Artificial Intelligence (AI) expertise primarily through the AI Dynamic Purchasing System (DPS). This agreement provides a flexible route for the public sector to procure AI services f...
Answered 24 Feb 2026
Original Parliament recordParking Offences: FinesDepartment for TransportTabled 2 Feb 2026AnsweredUIN 110048More
Question: To ask the Secretary of State for Transport, what information her Department holds on the extent to which enforcement authorities, when rejecting challenges to parking contravention notices during the discount period, re-offer the discount for a further 1
Answer: The Department for Transport does not hold this data as local authorities do not share this with the Department.
Answered 9 Feb 2026
Original Parliament recordTrade Agreements: USADepartment for Business and TradeTabled 12 Dec 2025AnsweredUIN 99524More
Question: To ask the Secretary of State for Business and Trade, if he will publish the full legal texts establishing the MFN mitigations with the US.
Answer: The UK has secured a zero percent tariff on all pharmaceuticals exported to the US - the lowest rate offered to any country. We have also secured preferential terms for the UK’s medical technology exports for three years, meaning no additional new tariffs...
Answered 17 Dec 2025
Original Parliament recordDrugs: USADepartment for Business and TradeTabled 12 Dec 2025AnsweredUIN 99523More
Question: To ask the Secretary of State for Business and Trade, pursuant to the answer of 10 December 2025 to Question 97685, whether any additional commitments have been made by the UK in relation to UK-US agreement on pharmaceutical in addition to the increased s
Answer: The UK has secured a zero percent tariff on all pharmaceuticals exported to the US - the lowest rate offered to any country. We have also secured preferential terms for the UK’s medical technology exports for three years, meaning no additional new tariffs...
Answered 17 Dec 2025
Original Parliament recordDrugs: USADepartment for Business and TradeTabled 12 Dec 2025AnsweredUIN 99522More
Question: To ask the Secretary of State for Business and Trade, pursuant to the answer of 9 December 2025 to Question 97256, what his planned timeframe is for the further work to finalise underpinning details to be completed.
Answer: The UK has secured a zero percent tariff on all pharmaceuticals exported to the US - the lowest rate offered to any country. We have also secured preferential terms for the UK’s medical technology exports for three years, meaning no additional new tariffs...
Answered 17 Dec 2025
Original Parliament recordNHS: DrugsDepartment of Health and Social CareTabled 10 Dec 2025AnsweredUIN 98909More
Question: To ask the Secretary of State for Health and Social Care, whether the UK is (a) excluded from, (b) partially exempted from and (c) otherwise subject to special treatment under the United States’ Most Favoured Nation drug pricing policy.
Answer: Thanks to strong United Kingdom support for innovation, the UK has secured mitigations under the United States’ ‘Most Favoured Nation’ drug pricing initiative so that we will continue to ensure access to the latest treatments. This will encourage pharmace...
Answered 17 Dec 2025
Original Parliament recordTelecommunications: InfrastructureDepartment for Science, Innovation and TechnologyTabled 10 Dec 2025AnsweredUIN 98906More
Question: To ask the Secretary of State for Science, Innovation and Technology, whether it is still her Department’s policy to finalise s61-64 of the Product Security and Telecommunications Infrastructure Act 2022, relating to renewal agreements, by the end of 2025
Answer: As per the commitment made in the Written Ministerial Statement on 21 July 2025, on 15 December 2025 the Department made regulations implementing Sections 61 – 64 of the Product Security and Telecommunications Infrastructure Act 2022 and published its res...
Answered 18 Dec 2025
Original Parliament recordTelecommunications: InfrastructureDepartment for Science, Innovation and TechnologyTabled 10 Dec 2025AnsweredUIN 98905More
Question: To ask the Secretary of State for Science, Innovation and Technology, when she plans to publish her Department's response to the consultation entitled Draft regulations to commence Sections 61 to 64 of the Product Security and Telecommunications Infrastru
Answer: As per the commitment made in the Written Ministerial Statement on 21 July 2025, on 15 December 2025 the Department made regulations implementing Sections 61 – 64 of the Product Security and Telecommunications Infrastructure Act 2022 and published its res...
Answered 18 Dec 2025
Original Parliament recordDrugs: USADepartment for Business and TradeTabled 5 Dec 2025AnsweredUIN 97685More
Question: To ask the Secretary of State for Business and Trade, with reference to the US Trade Representative's press release entitled U.S. Government Announces Agreement in Principle with the United Kingdom on Pharmaceutical Pricing, published on 1 December 2025,
Answer: As set out by the Secretary of State in his written statement to Parliament on 2 December, we have secured a zero percent tariff on all pharmaceuticals exported to the US - the lowest rate offered to any country. The UK has also secured preferential terms...
Answered 10 Dec 2025
Original Parliament recordNHS: DrugsDepartment of Health and Social CareTabled 5 Dec 2025AnsweredUIN 97665More
Question: To ask the Secretary of State for Health and Social Care, whether the capped VPAG rate referred to in the UK-US Economic Prosperity Deal will only apply to pharmaceutical products of US origin.
Answer: The capped rate applies to all newer medicines, not just pharmaceutical products originating from the United States.
Answered 17 Dec 2025
Original Parliament recordDrugs: USADepartment for Business and TradeTabled 5 Dec 2025AnsweredUIN 97663More
Question: To ask the Secretary of State for Business and Trade, what mechanisms within the UK-US Economic Prosperity Deal will ensure that pharmaceutical products launched in the UK with a lower price than in the US will not trigger Most Favoured Nation rebates.
Answer: We have secured the first and only deal with the US that delivers zero percent tariffs on pharmaceutical products – the lowest rate offered to any country. It delivers mitigations on the US’ ‘Most Favoured Nation’ policy and preferential terms for UK medt...
Answered 10 Dec 2025
Original Parliament record
Published records only — not a full account of an MP’s work. How we work →